Cargando…

Glucagon-like peptide (GLP) -2 improved colonizing bacteria and reduced severity of ulcerative colitis by enhancing the diversity and abundance of intestinal mucosa

The global incidence of ulcerative colitis (UC) continues to increase while it’s clinical cure rate remains low. Intestinal mucosal ulcers have segmental distribution and variable severity. Intestinal bacteria are closely related to intestinal immunity and metabolism; however, the relationship betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dongyue, Yang, Youlin, Yin, Xunhai, Liu, Yang, Xu, Hongyu, Ni, Yu, Hang, Ping, Niu, Sijia, Zhang, Huichao, Ding, Wenbo, Kuang, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806733/ https://www.ncbi.nlm.nih.gov/pubmed/34402720 http://dx.doi.org/10.1080/21655979.2021.1958600

Ejemplares similares

Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients
por: Osawa, Motoyasu, et al.
Publicado: (2023)

Integrative analysis revealed the role of glucagon-like peptide-2 in improving experimental colitis in mice by inhibiting inflammatory pathways, regulating glucose metabolism, and modulating gut microbiota
por: Li, Dongyue, et al.
Publicado: (2023)

The alleviating effect and mechanism of GLP-1 on ulcerative colitis
por: Wang, Wenrui, et al.
Publicado: (2023)

Glucagon, GLP-1 and Thermogenesis
por: González-García, Ismael, et al.
Publicado: (2019)

Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis
por: Du, Zhengyu, et al.
Publicado: (2015)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis
por: FAN, YUJING, et al.
Publicado: (2015)

Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis
por: Qiu, Xinyun, et al.
Publicado: (2017)

Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2019)

The Role of Bacteria in the Pathogenesis of Ulcerative Colitis
por: Sasaki, Maiko, et al.
Publicado: (2012)

Periplaneta americana extract promotes intestinal mucosa repair of ulcerative colitis in rat
por: Xue, Nan-nan, et al.
Publicado: (2020)

Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice
por: Chen, Lu, et al.
Publicado: (2017)

Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative Colitis
por: Dobre, Maria, et al.
Publicado: (2018)

Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis
por: Nishihara, Yuichiro, et al.
Publicado: (2021)

Is the Presence of Helicobacter Pylori in the Colonic Mucosa, Provocative of Activity in Ulcerative Colitis?
por: Ranjbar, Javad, et al.
Publicado: (2022)

Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
por: Zhao, Fenghui, et al.
Publicado: (2022)

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
por: Jin, Yue, et al.
Publicado: (2015)

Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice
por: Wei, Tianjiao, et al.
Publicado: (2023)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations
por: Xu, Dan, et al.
Publicado: (2022)

Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis
por: de Souza, Helton Luis, et al.
Publicado: (2012)

Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis
por: Cheng, Fang, et al.
Publicado: (2020)

Nasal mucosa pyoderma vegetans associated with ulcerative colitis: A case report
por: Yu, Shu-Xia, et al.
Publicado: (2020)

Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis
por: Ye, Xiaolin, et al.
Publicado: (2021)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

Ultrastructural Study on Colocalization of Glucagon-Like Peptide (GLP)-1 with GLP-2 in Chicken Intestinal L-Cells
por: NISHIMURA, Kei, et al.
Publicado: (2013)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

[Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures
por: Mieczkowska, Aleksandra, et al.
Publicado: (2021)

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
por: Helmstädter, Johanna, et al.
Publicado: (2021)

The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
por: Ørgaard, Anne, et al.
Publicado: (2017)

Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans
por: Modrzynska, Justyna, et al.
Publicado: (2021)

Correlation of CCL20 expression in rectal mucosa with the development of ulcerative colitis-associated neoplasia
por: HASHIMOTO, KIYOSHI, et al.
Publicado: (2013)

Mutations of p53 in Morphologically Non‐neoplastic Mucosa of Long‐standing Ulcerative Colitis
por: Takaku, Hideya, et al.
Publicado: (2001)

MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients
por: Valmiki, Swati, et al.
Publicado: (2017)

Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis by Downregulating Pro-inflammatory Cytokines in Mucosa and Serum
por: Zhang, Wen-Hui, et al.
Publicado: (2022)

Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes
por: Lang, Shan, et al.
Publicado: (2020)

Taking Aim at Islet Hormones With GLP-1: Is Insulin or Glucagon the Better Target?
por: D'Alessio, David A.
Publicado: (2010)

Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
por: Saraiva, Francisco Kerr, et al.
Publicado: (2014)

Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegeneration
por: Amato, Antonella, et al.
Publicado: (2019)

Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1)
por: Ang, Richard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_km15opl4f2deghbof43rgvtopl